Literature DB >> 12170889

The current status of curettage and electrodesiccation.

Glenn Goldman1.   

Abstract

Curettage and electrodesiccation (CE) is a technique widely used in the destruction of benign and selected malignant cutaneous neoplasms. CE is used mainly by dermatologists and family practice physicians, whereas plastic surgeons and other surgeons excise most benign and malignant lesions. The use of CE for the treatment of skin cancer has been widely extolled and also fervently criticized. Some practitioners treat most non-melanoma skin cancers (NMSC) with CE, and others have called for abandoning the technique in the treatment of such lesions. A thorough review of the literature reveals that CE has both virtues and flaws. In taking a rational approach to the treatment of benign and malignant cutaneous lesions it is essential to learn the basis for CE, the likely cure rates for given lesions, the proper technique, and the expected level of cosmesis. As the surgical treatment of skin cancer has become firmly entrenched in the field of dermatology, it is valuable to examine this technique in depth and to come to some thoughtful conclusions about its use for patients with skin cancer and assorted benign skin lesions. Last year a remarkably complete and exhaustive favorable review of curettage, electrosurgery, and skin cancer was published by Sheridan and Dawber. This article is a must read for anyone performing curettage; however, the author is writing with a slightly different perspective, that of a dermatologic surgeon. Although the author believes that CE has value and he uses this technique frequently, he disagrees with some of the truisms expressed in the literature about CE and attempts to define carefully what he believes are the strengths and limitations of this technique.

Entities:  

Mesh:

Year:  2002        PMID: 12170889     DOI: 10.1016/s0733-8635(02)00022-0

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Cutaneous squamous cell carcinoma of the head and neck.

Authors:  Vivek V Gurudutt; Eric M Genden
Journal:  J Skin Cancer       Date:  2011-02-21

Review 2.  Advances in the management of basal cell carcinoma.

Authors:  Jesse M Lewin; John A Carucci
Journal:  F1000Prime Rep       Date:  2015-05-12

3.  Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients.

Authors:  Kathleen M Nemer; Tyler M Bauman; M Laurin Council; Eva A Hurst
Journal:  Int J Womens Dermatol       Date:  2019-11-07

Review 4.  Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.

Authors:  Olivia M Chen; Keemberly Kim; Chelsea Steele; Kelly M Wilmas; Nader Aboul-Fettouh; Carrick Burns; Hung Quoc Doan; Sirunya Silapunt; Michael R Migden
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575

5.  A very interesting traditional method in the treatment of skin lesions: aqua regia and related complications.

Authors:  Fatih Doğan; Cemal Alper Kemaloğlu
Journal:  Springerplus       Date:  2016-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.